BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
+13.81%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$7.53B
AUM Growth
+$567M
(+8.1%)
Cap. Flow
-$9.29M
Cap. Flow
% of AUM
-0.12%
Top 10 Holdings %
Top 10 Hldgs %
36.11%
Holding
184
New
8
Increased
71
Reduced
51
Closed
13
Top Buys
| 1 |
Incyte
INCY
|
$17.1M |
| 2 |
Intuitive Surgical
ISRG
|
$15.7M |
| 3 |
DexCom
DXCM
|
$14.5M |
| 4 |
Centene
CNC
|
$13.5M |
| 5 |
Abbott
ABT
|
$12.6M |
Top Sells
| 1 |
ABMD
Abiomed Inc
ABMD
|
$40.9M |
| 2 |
UnitedHealth
UNH
|
$38.4M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$32.9M |
| 4 |
Elevance Health
ELV
|
$27.2M |
| 5 |
Molina Healthcare
MOH
|
$18M |
Sector Composition
| 1 | Healthcare | 99.55% |
| 2 | Industrials | 0.38% |
| 3 | Energy | 0.03% |
| 4 | Communication Services | 0.01% |
| 5 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Teladoc Health
TDOC
$1.37B
| $9.23M | 0.12% |
390,286
| – | – |
|
102
Biogen
BIIB
$20.5B
| $7.87M | 0.1% |
28,404
-331
| -1% | -$91.7K |
|
|
ONC
103
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.5B
| $7.71M | 0.1% |
34,500
+27,500
| +393% | +$6.15M |
|
104
Natera
NTRA
$23B
| $6.98M | 0.09% |
+173,812
| New | +$6.98M |
|
105
Dr. Reddy's Laboratories
RDY
$11.8B
| $6.43M | 0.09% |
627,500
+565,500
| +912% | +$5.8M |
|
|
OLK
106
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $6.38M | 0.08% |
251,185
+20,663
| +9% | +$524K |
|
107
BioMarin Pharmaceuticals
BMRN
$11.3B
| $6.28M | 0.08% |
60,685
+7,192
| +13% | +$744K |
|
108
Teleflex
TFX
$5.57B
| $6.26M | 0.08% |
25,066
-6,414
| -20% | -$1.6M |
|
109
Aurinia Pharmaceuticals
AUPH
$1.58B
| $5.57M | 0.07% |
1,290,278
-1,556,179
| -55% | -$6.72M |
|
110
American Well
AMWL
$112M
| $5.53M | 0.07% |
97,621
+9,136
| +10% | +$517K |
|
111
AstraZeneca
AZN
$255B
| $4.65M | 0.06% |
68,500
+24,100
| +54% | +$1.64M |
|
112
Johnson & Johnson
JNJ
$429B
| $4.6M | 0.06% |
26,027
-4,644
| -15% | -$820K |
|
113
Eli Lilly
LLY
$661B
| $4.04M | 0.05% |
11,055
+1,565
| +16% | +$573K |
|
114
Supernus Pharmaceuticals
SUPN
$2.52B
| $3.96M | 0.05% |
111,046
-8,232
| -7% | -$294K |
|
|
MTEM
115
DELISTED
Molecular Templates, Inc.
MTEM
| $3.7M | 0.05% |
751,867
| – | – |
|
116
Guardant Health
GH
$8.11B
| $3.68M | 0.05% |
135,455
+73,372
| +118% | +$2M |
|
117
Bristol-Myers Squibb
BMY
$96.7B
| $3.62M | 0.05% |
50,255
+43,193
| +612% | +$3.11M |
|
118
Sight Sciences
SGHT
$199M
| $3.6M | 0.05% |
294,606
| – | – |
|
|
SGEN
119
DELISTED
Seagen Inc. Common Stock
SGEN
| $2.91M | 0.04% |
22,626
-20,300
| -47% | -$2.61M |
|
120
Zai Lab
ZLAB
$3.48B
| $2.84M | 0.04% |
90,000
+53,400
| +146% | +$1.68M |
|
121
AbbVie
ABBV
$374B
| $2.62M | 0.03% |
16,200
-797
| -5% | -$129K |
|
122
Cytokinetics
CYTK
$5.98B
| $2.48M | 0.03% |
54,200
-17,000
| -24% | -$779K |
|
123
Akero Therapeutics
AKRO
$3.65B
| $2.34M | 0.03% |
42,650
+1,016
| +2% | +$55.7K |
|
|
BCYC
124
Bicycle Therapeutics
BCYC
$492M
| $2.08M | 0.03% |
70,200
-27,900
| -28% | -$826K |
|
125
Q32 Bio
QTTB
$20.9M
| $2.04M | 0.03% |
90,140
| – | – |
|